PERRY BABCOCK: Open Payments
NPI 1750842167 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 51 payments from 16 companies in 2025. Trend: 2023 $549 · 2024 $601 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $213 |
| Vanda Pharmaceuticals Inc. | 4 | $104 |
| Braeburn Inc. | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Indivior Inc. | 2 | $49 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Orexo US, Inc. | 1 | $25 |
Products named: FANAPT, REXULTI, BRIXADI, VRAYLAR, UBRELVY, QULIPTA, SUBLOCADE, MAVYRET.
Industry payments across KY — which companies pay providers there.
